GSK Pharma Q2 net up 14% at Rs 147 cr

GlaxoSmithKline Pharmaceuticals today said its net profit rose by 14.38% to Rs 147.54 crore for the second quarter ended June 30.

The company had posted a net profit of Rs 128.99 crore in the same period previous fiscal, it said in a filing to the Bombay Stock Exchange (BSE).

The company's net sales rose to Rs 561.54 crore for the second quarter as compared to Rs 497.93 crore in the same period last financial year.

Commenting on the results GlaxoSmithKline Pharmaceuticals MD Hasit B Joshipura said: "The company's growth has been in line with the market growth. In particular,oncology, dermatologicals and mass speciality therapies have grown well. In addition to the base effect, vaccines has shown strong market competitive growth."

 

Shares of GlaxoSmithKline Pharmaceuticals today closed at Rs 2,122 on the BSE, up 0.24% from their previous close.